[
    "{\"step_by_step_thinking\": \"Document 0 mentions that BNN20 treatment leads to an increased number of mature oligodendrocytes in a mouse model. It also reduces microglial activation and their transition to their pro-inflammatory state. Document 2 mentions that BNN-20 exerts a potent neuroprotective effect on the 'weaver' mouse, a genetic model of progressive, nigrostriatal dopaminergic degeneration, which is a characteristic of Parkinson's disease. Document 3 also mentions that BNN-20 exhibits a pleiotropic neuroprotective effect on the dopaminergic neurons of the SNpc in the 'weaver' mouse model of PD. Therefore, it can be concluded that BNN20 is involved in Parkinson's disease.\", \"answer_choice\": \"A\"}"
]